Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb;146(3):354-358.
doi: 10.1017/S0950268817003090. Epub 2018 Jan 15.

Clinical characteristics of non-tuberculous mycobacterial pulmonary infections in Bamako, Mali

B Kone  1 , Y S Sarro  1 , M Maiga  1 , M Sanogo  1 , A M Somboro  1 , B Diarra  1 , A C G Togo  1 , N Coulibaly  1 , B P P Dembele  1 , D Goita  1 , B Baya  1 , A Kone  1 , S Diabaté  1 , M A Polis  2 , M Belson  2 , S Dao  1 , S Orsega  2 , C J Achenbach  3 , R L Murphy  3 , S Diallo  1 , S Siddiqui  2
Affiliations

Clinical characteristics of non-tuberculous mycobacterial pulmonary infections in Bamako, Mali

B Kone et al. Epidemiol Infect. 2018 Feb.

Abstract

The global spread of non-tuberculous mycobacteria (NTM) may be due to HIV/AIDS and other environmental factors. The symptoms of NTM and tuberculosis (TB) disease are indistinguishable, but their treatments are different. Lack of research on the epidemiology of NTM infections has led to underestimation of its prevalence within TB endemic countries. This study was designed to determine the prevalence and clinical characteristics of pulmonary NTM in Bamako. A cross-sectional study which include 439 suspected cases of pulmonary TB. From 2006 to 2013 a total of 332 (76%) were confirmed to have sputum culture positive for mycobacteria. The prevalence of NTM infection was 9.3% of our study population and 12.3% of culture positive patients. The seroprevalence of HIV in NTM group was 17.1%. Patients who weighed <55 kg and had TB symptoms other than cough were also significantly more likely to have disease due to NTM as compared to those with TB disease who were significantly more likely to have cough and weigh more than 55 kg (OR 0.05 (CI 0.02-0.13) and OR 0.32 (CI 0.11-0.93) respectively). NTM disease burden in Bamako was substantial and diagnostic algorithms for pulmonary disease in TB endemic countries should consider the impact of NTM.

Keywords: Bamako; clinical characteristics; non-tuberculous mycobacteria; tuberculosis.

PubMed Disclaimer

Conflict of interest statement

None of the authors has a conflict of interest.

Figures

Fig. 1.
Fig. 1.
Descriptive groups of the study.
Fig. 2.
Fig. 2.
Distribution of the 20 non-tuberculosis mycobacteria species in Bamako, Mali.
See this image and copyright information in PMC

References

    1. Tortoli E (2003) Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clinical Microbiology Reviews 16(2), 319–354. - PMC - PubMed
    1. Prevots DR and Marras TK (2015) Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clinics in Chest Medicine 36(1), 13–34. - PMC - PubMed
    1. Al Jarad N, et al. (1996) Comparison of characteristics of patients and treatment outcome for pulmonary nontuberculous mycobacterial infection and pulmonary tuberculosis. Thorax 51(2), 137–139. - PMC - PubMed
    1. Maiga M, et al. (2012) Failure to recognize nontuberculous mycobacteria leads to misdiagnosis of chronic pulmonary tuberculosis. PLoS ONE 7(5), e36902. - PMC - PubMed
    1. Griffith DE, et al. (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine 175(4), 367–416. - PubMed

Publication types